The Role Fasting In Metabolism And Tumor Progressive
DOI:
https://doi.org/10.46966/msjar.v3i2.40Keywords:
Keywords: FASTING, IGF1, FMD, IGFBP1, GH.Abstract
Background: Fasting is the voluntary abstinence from food and drink for a fixed period of time while remaining faithful to certain rules. Fasting has been practiced by humans since ancient time. Fasting involved in the regulation of many metabolic processes correlated with transitioning into a process capable of Energy production and carbon-based metabolism mainly from Tissue adipose and muscular parts. The differences in the levels in the blood hormones and metabolites help to lower and eventually defend normal cells from chemical insults in the cell division and metabolic activityFasting Can induce an anti-warburg response by reducing glucose absorption Carriers (GLUTs) and aerobic glycolysis and force cancer cells to Improve in oxidative phosphorylation (OxPhos); It improves efficiency in cancer cells and, subsequently, toxic products of reactive oxygen (ROS). DNA, p53, DNA damage , and death of the cells , particularly Chemotherapy response,Fasting serves as improving anti-tumour immunity By Fasting or FMD.
Conclusion Fasting regulates many physiological functions associated with transitioning into a process capable of producing energy and carbon-based metabolic activity mainly from adipose and muscular tissue., The fasting action is largely dictated by the levels of glucose, glucagon, insulin, GH, IGF1, and adrenaline in the blood.,Some many discrepancy in the rates at which hormones and metabolites circulate are normally found during fasting, allowing antitumor response . ,fasting reaction Protects significant nerves and glia but still doesn't prevent glioma or neuroblastoma, Cyclophosphamide, and pro-oxidant Compounds, and preserves the embryonic mouse Doxorubicide fibroblasts.
References
Natarajan, S., Kannan, M., Sathiyarajeswaran, P., Gopakumar, K., Pandian, S. J. J., & Ramaswamy, R. S. FASTING-A MEDICO HISTORICAL OVERVIEW.
Lee, C., Raffaghello, L., Brandhorst, S., Safdie, F. M., Bianchi, G., Martin-Montalvo, A., ... & Emionite, L. (2012). Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Science translational medicine, 4(124), 124ra27-124ra27.
Raffaghello, L., Lee, C., Safdie, F. M., Wei, M., Madia, F., Bianchi, G., & Longo, V. D. (2008). Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proceedings of the National Academy of Sciences, 105(24), 8215-8220.
Pelt, A. C. (2010). Glucocorticoids: effects, action mechanisms, and therapeutic uses. Nova Science Publishers, Incorporated.
Khurana, I. (2008). Essentials of medical physiology. Intia: Elsevier India.
Brandhorst, S., Wei, M., Hwang, S., Morgan, T. E., & Longo, V. D. (2013). Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Experimental gerontology, 48(10), 1120-1128.
Brennan, A. M., & Mantzoros, C. S. (2006). Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications. Nature clinical practice Endocrinology & metabolism, 2(6), 318-327.
Raffaghello, L., Lee, C., Safdie, F. M., Wei, M., Madia, F., Bianchi, G., & Longo, V. D. (2008). Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proceedings of the National Academy of Sciences, 105(24), 8215-8220.
Wei, M., Fabrizio, P., Hu, J., Ge, H., Cheng, C., Li, L., & Longo, V. D. (2008). Life span extension by calorie restriction depends on Rim15 and transcription factors downstream of Ras/PKA, Tor, and Sch9. PLoS Genet, 4(1), e13.
Nencioni, A., Caffa, I., Cortellino, S., & Longo, V. D. (2018). Fasting and cancer: molecular mechanisms and clinical application. Nature Reviews Cancer, 18(11), 707-719.
Brandhorst, S., Choi, I. Y., Wei, M., Cheng, C. W., Sedrakyan, S., Navarrete, G., ... & Di Biase, S. (2015). A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell metabolism, 22(1), 86-99.
Cheng, Z., Guo, S., Copps, K., Dong, X., Kollipara, R., Rodgers, J. T., ... & White, M. F. (2009). Foxo1 integrates insulin signaling with mitochondrial function in the liver. Nature medicine, 15(11), 1307-1311.
Brandhorst, S., Choi, I. Y., Wei, M., Cheng, C. W., Sedrakyan, S., Navarrete, G., ... & Di Biase, S. (2015). A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell metabolism, 22(1), 86-99.
Chalkiadaki, A., & Guarente, L. (2015). The multifaceted functions of sirtuins in cancer. Nature Reviews Cancer, 15(10), 608-624.
Yang, H., Yang, T., Baur, J. A., Perez, E., Matsui, T., Carmona, J. J., ... & de Cabo, R. (2007). Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell, 130(6), 1095-1107.
Brennan, A. M., & Mantzoros, C. S. (2006). Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications. Nature clinical practice Endocrinology & metabolism, 2(6), 318-327.
Jardé, T., Perrier, S., Vasson, M. P., & Caldefie-Chézet, F. (2011). Molecular mechanisms of leptin and adiponectin in breast cancer. European journal of cancer, 47(1), 33-43.
Pollak, M. (2012). The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nature Reviews Cancer, 12(3), 159-169.
Newman, J. C., & Verdin, E. (2014). Ketone bodies as signaling metabolites. Trends in Endocrinology & Metabolism, 25(1), 42-52.
Xia, S., Lin, R., Jin, L., Zhao, L., Kang, H. B., Pan, Y., ... & Zhang, B. (2017). Prevention of dietary-fat-fueled ketogenesis attenuates BRAF V600E tumor growth. Cell metabolism, 25(2), 358-373.
Cheng, C. W., Adams, G. B., Perin, L., Wei, M., Zhou, X., Lam, B. S., ... & Kopchick, J. J. (2014). Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell stem cell, 14(6), 810-823.
Xia, S., Lin, R., Jin, L., Zhao, L., Kang, H. B., Pan, Y., ... & Zhang, B. (2017). Prevention of dietary-fat-fueled ketogenesis attenuates BRAF V600E tumor growth. Cell metabolism, 25(2), 358-373.
Cheng, C. W., Adams, G. B., Perin, L., Wei, M., Zhou, X., Lam, B. S., ... & Kopchick, J. J. (2014). Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell stem cell, 14(6), 810-823.
Lee, C., Safdie, F. M., Raffaghello, L., Wei, M., Madia, F., Parrella, E., ... & Longo, V. D. (2010). Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer research, 70(4), 1564-1572.
Di Biase, S., Lee, C., Brandhorst, S., Manes, B., Buono, R., Cheng, C. W., ... & Morgan, T. E. (2016). Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer cell, 30(1), 136-146.
Lee, C., Raffaghello, L., Brandhorst, S., Safdie, F. M., Bianchi, G., Martin-Montalvo, A., ... & Emionite, L. (2012). Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Science translational medicine, 4(124), 124ra27-124ra27.
Nencioni, A., Caffa, I., Cortellino, S., & Longo, V. D. (2018). Fasting and cancer: molecular mechanisms and clinical application. Nature Reviews Cancer, 18(11), 707-719.
Lee, C., Raffaghello, L., Brandhorst, S., Safdie, F. M., Bianchi, G., Martin-Montalvo, A., ... & Emionite, L. (2012). Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Science translational medicine, 4(124), 124ra27-124ra27.
Lee, C., Raffaghello, L., Brandhorst, S., Safdie, F. M., Bianchi, G., Martin-Montalvo, A., ... & Emionite, L. (2012). Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Science translational medicine, 4(124), 124ra27-124ra27.
Brennan, A. M., & Mantzoros, C. S. (2006). Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications. Nature clinical practice Endocrinology & metabolism, 2(6), 318-327
Nencioni, A., Caffa, I., Cortellino, S., & Longo, V. D. (2018). Fasting and cancer: molecular mechanisms and clinical application. Nature Reviews Cancer, 18(11), 707-719.
Pietrocola, F., Pol, J., Vacchelli, E., Rao, S., Enot, D. P., Baracco, E. E., ... & Senovilla, L. (2016). Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer cell, 30(1), 147-160.
Antunes, F., Erustes, A. G., Costa, A. J., Nascimento, A. C., Bincoletto, C., Ureshino, R. P., ... & Smaili, S. S. (2018). Autophagy and intermittent fasting: the connection for cancer therapy?. Clinics, 73.
Antunes, F., Erustes, A. G., Costa, A. J., Nascimento, A. C., Bincoletto, C., Ureshino, R. P., ... & Smaili, S. S. (2018). Autophagy and intermittent fasting: the connection for cancer therapy?. Clinics, 73.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Zainab Abdullah Waheed, Nadia Habeeb Sarhan , Mustafa Mohammed Shaker, Israa Mahmood Kadhim AL-Zubaidy, Hawraa Ghaleb Idreess
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
